title: Site occupancy and glycan compositional analysis of two soluble recombinant forms of the attachment glycoprotein of Hendra virus.
abstract: Hendra virus (HeV) continues to cause morbidity and mortality in both humans and horses with a number of sporadic outbreaks. HeV has two structural membrane glycoproteins that mediate the infection of host cells: the attachment (G) and the fusion (F) glycoproteins that are essential for receptor binding and virion-host cell membrane fusion, respectively. N-linked glycosylation of viral envelope proteins are critical post-translation modifications that have been implicated in roles of structural integrity, virus replication and evasion of the host immune response. Deciphering the glycan composition and structure on these glycoproteins may assist in the development of glycan-targeted therapeutic intervention strategies. We examined the site occupancy and glycan composition of recombinant soluble G (sG) glycoproteins expressed in two different mammalian cell systems, transient human embryonic kidney 293 (HEK293) cells and vaccinia virus (VV)-HeLa cells, using a suite of biochemical and biophysical tools: electrophoresis, lectin binding and tandem mass spectrometry. The N-linked glycans of both VV and HEK293-derived sG glycoproteins carried predominantly mono- and disialylated complex-type N-glycans and a smaller population of high mannose-type glycans. All seven consensus sequences for N-linked glycosylation were definitively found to be occupied in the VV-derived protein, whereas only four sites were found and characterized in the HEK293-derived protein. We also report, for the first time, the existence of O-linked glycosylation sites in both proteins. The striking characteristic of both proteins was glycan heterogeneity in both N- and O-linked sites. The structural features of G protein glycosylation were also determined by X-ray crystallography and interactions with the ephrin-B2 receptor are discussed.
authors.affiliation: Queensland Bioscience Precinct, CSIRO Livestock Industries, St Lucia, QLD 4067, Australia.
authors.forename: Michelle L
authors.initials: ML
authors.lastname: Colgrave
authors.forename: Hayley J
authors.initials: HJ
authors.lastname: Snelling
authors.forename: Brian J
authors.initials: BJ
authors.lastname: Shiell
authors.forename: Yan-Ru
authors.initials: YR
authors.lastname: Feng
authors.forename: Yee-Peng
authors.initials: YP
authors.lastname: Chan
authors.forename: Katharine N
authors.initials: KN
authors.lastname: Bossart
authors.forename: Kai
authors.initials: K
authors.lastname: Xu
authors.forename: Dimitar B
authors.initials: DB
authors.lastname: Nikolov
authors.forename: Christopher C
authors.initials: CC
authors.lastname: Broder
authors.forename: Wojtek P
authors.initials: WP
authors.lastname: Michalski
mesh_terms: D020816:Amino Acid Motifs; D000595:Amino Acid Sequence; D002236:Carbohydrate Conformation; D002240:Carbohydrate Sequence; D018360:Crystallography, X-Ray; D024202:Electrophoretic Mobility Shift Assay; D006031:Glycosylation; D057809:HEK293 Cells; D006367:HeLa Cells; D045404:Hendra Virus; D006801:Humans; D037102:Lectins / Q000737:chemistry; D008958:Models, Molecular; D008969:Molecular Sequence Data; D010446:Peptide Fragments / Q000737:chemistry; D011134:Polysaccharides / Q000737:chemistry*; D011485:Protein Binding; D020836:Protein Structure, Quaternary; D036183:Receptor, EphB2 / Q000737:chemistry; D011994:Recombinant Proteins / Q000737:chemistry; D020539:Sequence Analysis, Protein; D014759:Viral Envelope Proteins / Q000737:chemistry*
chemical_list: D037102:Lectins; D010446:Peptide Fragments; D011134:Polysaccharides; D011994:Recombinant Proteins; D014759:Viral Envelope Proteins; C116204:attachment protein G; D036183:Receptor, EphB2